Neurochirurgie
-
Review Clinical Trial
[Management of intractable cancer pain: from intrathecal morphine to cell allograft].
The durable effectiveness of intrathecal morphine administration is well established for the management of intractable cancer pain, after failure of systemic opioids, secondary to the persistence of non-reversible undesirable side effects. Many patients are referred to late in the disease course. This conservative method to control pain of malignant origin must not be reserved for last resort treatment for terminal patients. ⋯ Convincing evidence will require controlled studies. The limitations of this innovative cell therapy and especially the lack of human adrenal gland availability point to the need for new sources of cells. Perspectives include xenogenic or engineered cell lines.
-
Different types of neurostimulation are proposed essentially in cases of chronic neuropathic pain, non controlled by anticonvulsivants and antidepressants. The aim is usually to activate a failing inhibitory system, involved in the transmission and the modulation of the nociceptive stimulus. The site of stimulation (transcutaneous, spinal cord, thalamic) is choosen according to the severity of pain and especially the degree of lemniscal dysfunction evaluated by clinical and electrophysiological data. ⋯ When dysfunction or lesion extend to the pre-ganglionic portion, it's preferable to propose stereotactic thalamic stimulation or central gyrus stimulation. The analgesic effect concerns permanent burning pain in the context of sensitive deafferentation: after distal nervous lesions, radicular, plexular or spinal lesions or after stroke with ischemic lesions along the nociceptive pathways. These different methods must only be proposed if there is a frequent clinical and technical monitoring.